Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
How Pharmacists Are Leading the Charge in Immunizations and Generic Prescriptions
Dec, 1 2025
Lamivudine Cost-Effectiveness for HIV and Hepatitis B Treatment: Real-World Insights
May, 11 2025
Goldenseal and Metformin Interaction Risks for Blood Sugar Control
Dec, 30 2025
How the FDA Monitors Generic Drug Safety After Approval
Dec, 7 2025
Antibiotic Resistance: Understanding Why Your Medication Changes and New Treatment Choices
Apr, 26 2025